Lincoln Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹612₹62552 Week's Low
52 Week's High
₹534.8₹811.85
| Returns % | |
| 1 Month Return | -5.65 % |
| 3 Month Return | -12.81 % |
| 1 Year Return | -5.77 % |
| Market Stats | |
| Previous Close | ₹623.45 |
| Open | ₹625.00 |
| Volume | 31.21K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,248.75Cr |
Lincoln Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 12.92 |
| PEG Ratio | 1.64 |
| Market Cap | ₹1,248.75 Cr |
| P/B Ratio | 1.98 |
| EPS | 46.58 |
| Dividend Yield | 0.31 |
| Sector | Pharmaceuticals |
| ROE | 17.04 |
Lincoln Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,248.75 Cr | 49.72% | 0.50 | ₹93 Cr | ₹580 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Lincoln Pharmaceuticals Ltd
Share Price: ₹617.20 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹1,248.75Cr as of today
Revenue: ₹161.21Cr as on September 2024 (Q3 24)
Net Profit: ₹26.33Cr as on September 2024 (Q3 24)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
| Organisation | Lincoln Pharmaceuticals Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Reports Q2 FY25 Results - 14 Nov, 2024
Lincoln Pharmaceuticals reported Q2 FY25 revenue of ₹161.21 crore, up 3.4% YoY, but net profit fell 4.8% YoY to ₹26.33 crore. QoQ, revenue and net profit showed positive growth.
Insights on Lincoln Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 3.95% to 5.19% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 149.51 Cr → 171.19 Cr (in ₹), with an average increase of 6.5% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 18.6 Cr → 26.33 Cr (in ₹), with an average increase of 15.8% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 49.78% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 32.1%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 64.3%
NEGATIVE IMPACTPrice Dip
In the last 3 months, LINCOLN stock has moved down by -12.8%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 46.24% to 45.03% in Sep 2024 quarter
Lincoln Pharmaceuticals Ltd Financials
Index Inclusions
Lincoln Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.78% | 0.00 | |
| Foreign Institutions | 5.19% | 31.48 | |
| Mutual Funds | 0% | 85.71 | |
| Retail Investors | 45.03% | ||
| Others | 0% |
Lincoln Pharmaceuticals Ltd Key Indicators
Lincoln Pharmaceuticals Ltd Valuation
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (12.92x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (18.47x)
January 23, 2018
Lincoln Pharmaceuticals Ltd Earnings and Dividends
Lincoln Pharmaceuticals Ltd Earnings Results
Lincoln Pharmaceuticals Ltd’s net profit fell -4.77% since last year same period to ₹26.33Cr in the Q2 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 11.24% jump in its net profits since last 3-months.
Read More about Earnings ResultsLincoln Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 - translating a dividend yield of 0.53%.
Read More about Dividends
Lincoln Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Lincoln Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Lincoln Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Lincoln Pharmaceuticals Ltd shares.
Lincoln Pharmaceuticals Ltd (LINCOLN) share price today is ₹617.2
Lincoln Pharmaceuticals Ltd is listed on NSE
Lincoln Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Lincoln Pharmaceuticals Ltd is ₹625.
- Today’s lowest price of Lincoln Pharmaceuticals Ltd is ₹612.
PE Ratio of Lincoln Pharmaceuticals Ltd is 12.92
PE ratio = Lincoln Pharmaceuticals Ltd Market price per share / Lincoln Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Lincoln Pharmaceuticals Ltd(LINCOLN) is 31.21K.
Today’s market capitalisation of Lincoln Pharmaceuticals Ltd(LINCOLN) is ₹1248.75Cr.
| Lincoln Pharmaceuticals Ltd(LINCOLN | Price |
|---|---|
52 Week High | ₹811.85 |
52 Week Low | ₹534.8 |
Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹617.2. It is down -23.98% from its 52 Week High price of ₹811.85
Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹617.2. It is up 15.41% from its 52 Week Low price of ₹534.8
| Lincoln Pharmaceuticals Ltd(LINCOLN | Returns |
|---|---|
1 Day Returns | -6.25% |
1 Month Returns | -5.65% |
3 Month Returns | -12.81% |
1 Year Returns | -5.77% |